One Test for 7 Deadly Diseases

One Test for Seven Deadly Diseases

~Metropolis makes testing easier for India’s billion-plus population~

Chennai, August 26, 2014: Metropolis Healthcare Ltd, a leading multinational chain of diagnostic centers, today launched India’s first single test for seven diseases which cause fever. The Multiplex PCR test helps diagnose seven common diseases causing fever i.e. Malaria, Dengue, Typhoid, Leptospirosis, Chikungunya, West Nile Fever and Rickettsia, thus saving cost and providing respite to people in a healthcare system that is getting more expensive and less inclusive by the day.

The Multiple PCR is done in real-time which extract nucleic acid of pathogens from whole blood. With a sensitivity and specificity of a 100%, the test looks to provide a breather in terms of diagnosis to a country where according to certain estimates, 80% of all illnesses are water-related. 

In India, for example, dengue, typhoid and malaria outbreaks are common place owing to poor sanitation and drainage system. The test thus looks to save time and money, whilst ensuring that treatment starts at the earliest, thus reducing the burden and the trauma upon the potential patient.

Speaking at the occasion, Dr. Nilesh Shah, Group President – Scientific Service & Operation, SBU Head – West India, Metropolis Healthcare Ltd. said, “Our effort to eliminate infectious diseases receives a boost today as we achieve an important milestone in diagnostics, by providing convenience in healthcare which help save time and lives. The test ensures earliest possible detection compared to all the conventional tests available. 

The patient may get diagnosed as early as on the 1^st day of the fever. Secondly, the test is a confirmatory unlike screening tests being used conventionally, which may have false positivity. Multiplex PCR test is expected to significantly facilitate fever screening and therefore speed up identification of patients suffering from various symptoms of infectious disease”.

Patients suffering from high fever are often put through a battery of tests to detect the cause of fever, leading to a delay in treatment. In a sphere as critical as healthcare, time thus becomes of prime importance, and this is the lacunae that Metropolis Healthcare looks to fill, in its efforts to make diagnostic dilemma obsolete.

ABOUT METROPOLIS HEALTHCARE LTD...

At Metropolis, what we believe is what we say and what we say is what we do. Being empathetic to our customers and being committed to their needs is in our DNA. Metropolis has grown to harness a culture that is open, synergistic, progressive and scientific in nature.

We are the Pathology Specialists delivering over 15 million tests a year, catering to more than 10,000 Laboratories, Hospitals, Nursing homes and 2,00,000 Consultants. With 33 years of experience in delivering accurate reports, Metropolis has earned the reputation of being India's most respected and only multinational chain of diagnostic centres with presence in UAE, Sri Lanka, South Africa, Kenya, Mauritius and Ghana.

Driven to make a difference, our wide network includes 105 state-of-art Laboratories across India with over 700 collection centres, processing over 4500 varieties of tests and supported by an efficient team of more than 3000 people. Equipped with cutting edge technology, innovative work equipment, expansive logistics network and rigorous processes, Metropolis ensures and delivers precision and accuracy in every single test; each time, every time.

In the last 10 years, Metropolis has expanded into new service lines like Clinical Trials, Hospital Lab Management, Home Health Services, Preventive Health Check-ups and Corporate & Wellness Solutions. Metropolis is at the forefront in adopting cutting edge technologies and services that contribute new revenue streams and has positioned the company on the pedestal it is today.

Today, we are one of the few laboratories that has received the CAP (College of American Pathologists), accreditation, the global gold standard in Laboratory Accreditation. 12 of our laboratories in India has received the NABL Accreditation (National Accreditation Board for testing and Calibration Laboratories). In addition, the central laboratory in Mumbai also adheres to CLIA (Clinical Laboratory Improvement Amendments) program and also follows the guidelines laid by GCP and GLP. Our unit in South Africa is accredited by SANAS (South African National Accreditation System is the only accreditation body approved by South African Government).

Metropolis has been awarded numerous accolades like the ‘Best Diagnostic Company of the year’ by Modern Medicare in 2006 and ‘Best Diagnostic Company of the Year’ in 2010 by Frost & Sullivan. Metropolis was also bestowed with ‘Best IT Integration in Customer Service Management’ at the e-Health World Expo 2011. Metropolis was also honoured with the ‘Quality Brand Award’ by NEHRDO in 2012. Metropolis won the ‘CMO Asia Award’ for Best IT practices in Healthcare in 2012.

Metropolis Healthcare is led by Ameera Shah, Managing Director & CEO. An International & National Award winners, she was conferred with ‘The Young entrepreneur of the Year Award’ by GE in 2006 and ‘The Young Achiever of the Year Award’ at the CMO Asia Awards in 2011. She was also the recipient of the prestigious ‘Young Entrepreneur of the Year Award’ in 2011 organised by Entrepreneur India and Bloomberg. She has been honoured with ‘Women Leadership award’ at the World Women Leadership and Congress awards 2014.  Recently she has been chosen as one of the most respected leaders under 40 years by Economic Times & Spencer Stuart (2014).

Share: